Yes, Hepatitis B vaccine and PCV20 can be given together
Hepatitis B vaccine and 20-valent pneumococcal conjugate vaccine (PCV20) can be safely administered concurrently at the same visit using separate injection sites. This recommendation is supported by longstanding ACIP guidance on simultaneous vaccine administration and recent clinical trial data specific to PCV20.
Evidence Supporting Concurrent Administration
General Principles from ACIP Guidelines
The Advisory Committee on Immunization Practices has consistently recommended simultaneous administration of all indicated vaccines since the early 1990s. Routinely administering all vaccines simultaneously is recommended for children who are the appropriate age to receive them and for whom no specific contraindications exist at the time of the visit 1.
Key supporting evidence includes:
- When hepatitis B vaccine has been administered at the same time as other vaccines, no interference with the antibody response of the other vaccines has been demonstrated 2
- Simultaneously administering the most widely used live and inactivated vaccines produces seroconversion rates and rates of adverse reactions similar to those observed when vaccines are administered separately 1
- Simultaneous administration increases the probability that a child will be fully immunized at the appropriate age 1
Specific Evidence for PCV20 with Hepatitis B Vaccine
Recent phase 3 clinical trials provide direct evidence for PCV20 coadministration. In Study B7471011, PCV20 was administered concomitantly with Pediarix (DTaP-HBV-IPV, which contains hepatitis B vaccine) at 2,4, and 6 months of age 3, 4. The study demonstrated:
- Noninferiority was met for immune responses to all concomitant vaccine antigens, including hepatitis B, when given with PCV20 compared to PCV13 4
- Safety profiles were similar between PCV20 and PCV13 groups 4
- Most systemic events were mild or moderate in severity 3
Practical Administration Guidelines
When administering both vaccines together:
- Use separate anatomical injection sites (e.g., different limbs) 5
- Do not mix vaccines in the same syringe unless specifically FDA-approved for mixing 1
- Follow age-appropriate dosing for each vaccine
- Document both vaccines in the patient's record and immunization information system
Clinical Context
This recommendation applies across age groups:
- Infants and children: Both vaccines are part of routine childhood immunization schedules and should be given together when indicated 1, 3
- Adults: For catch-up vaccination or those with specific indications, both vaccines can be administered at the same visit
Common Pitfalls to Avoid
- Do not delay either vaccine to separate them—this only increases the risk of incomplete immunization 1
- Do not assume increased adverse events from concurrent administration; clinical trial data show similar safety profiles 3, 4
- Do not require separate visits unless there is a specific medical contraindication to one of the vaccines
The evidence strongly supports concurrent administration as both safe and effective, with the added benefit of improving vaccination completion rates.